| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/10/1993 | CA1321281C Humoral hypercalcemic factor antagonists |
| 08/10/1993 | CA1321157C Plants genetically enhanced for disease resistance |
| 08/10/1993 | CA1321142C Mycoplasma hyopneumoniae antigen and uses therefor |
| 08/07/1993 | WO1993015754A1 Hepatic growth factor receptor |
| 08/07/1993 | CA2129423A1 Hepatic growth factor receptor |
| 08/06/1993 | CA2088804A1 Tgf-beta induced gene and protein |
| 08/06/1993 | CA2087781A1 Method of treating presenile or senile dementia |
| 08/05/1993 | WO1993015405A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 08/05/1993 | WO1993015227A1 Method of assaying for the oncogenic state of cells |
| 08/05/1993 | WO1993015216A1 Novel heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof |
| 08/05/1993 | WO1993015213A1 Control of gene transcription |
| 08/05/1993 | WO1993015212A1 Attenuated mutant of listeria monocytogenes; recombinant strain of listeria monocytogenes, use as heterologous vaccinal antigene vectors and use as vaccine or diagnostic composition |
| 08/05/1993 | WO1993015211A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides |
| 08/05/1993 | WO1993015210A1 Monomeric and dimeric antibody-fragment fusion proteins |
| 08/05/1993 | WO1993015207A2 Hepatitis therapeutics |
| 08/05/1993 | WO1993015206A2 Process for controlling scarab pests with bacillus thuringiensis isolates |
| 08/05/1993 | WO1993015205A2 Synthetic haemophilus influenzae conjugate vaccine |
| 08/05/1993 | WO1993015204A1 Serum-human albumin, preparation and utilization |
| 08/05/1993 | WO1993015203A2 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 08/05/1993 | WO1993015202A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | WO1993015201A1 Novel protein tyrosine kinases |
| 08/05/1993 | WO1993015200A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium |
| 08/05/1993 | WO1993015199A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/05/1993 | WO1993015198A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
| 08/05/1993 | WO1993015197A2 Expression of osteogenic factor op-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 08/05/1993 | WO1993015196A1 Dna encoding kappa-casein, process for obtaining the protein and use thereof |
| 08/05/1993 | WO1993015195A1 Granulins from leukocytes |
| 08/05/1993 | WO1993015194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 08/05/1993 | WO1993015193A1 Mammalian expression systems for hcv proteins |
| 08/05/1993 | WO1993015192A1 Insecticidally effective peptides |
| 08/05/1993 | WO1993015117A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 08/05/1993 | WO1993015114A1 Large, latent complexes of tgf-beta2 and tgf-beta3 |
| 08/05/1993 | WO1993015113A1 An immunotoxin including a cytotoxin with an unpaired cysteine residue in or near its receptor-binding site |
| 08/05/1993 | WO1993015112A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 08/05/1993 | WO1993015111A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 08/05/1993 | WO1993015110A1 Amino acid sequences which pair specifically |
| 08/05/1993 | WO1993015109A2 Parathyroid hormone fragments, their preparation and medicaments containing the same |
| 08/05/1993 | WO1993015108A1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders |
| 08/05/1993 | WO1993015107A1 Amino procollagen 1(i) peptides |
| 08/05/1993 | WO1993015106A1 Cyclic calcitonine derivatives and method for their production |
| 08/05/1993 | WO1993015105A1 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography |
| 08/05/1993 | WO1993015050A1 Immunological analogs for captan |
| 08/05/1993 | WO1993014789A1 Pathogen-specific ctl therapy |
| 08/05/1993 | WO1993014786A1 Composition and method to prevent conception or to cause sterility in animals |
| 08/05/1993 | WO1993014785A1 Immunotherapy for recurrent hsv infections |
| 08/05/1993 | WO1993014783A1 Growth factor compositions, preparation and use |
| 08/05/1993 | WO1993014782A1 Methods of controlling the proliferation of macrophages |
| 08/05/1993 | WO1993014781A1 Novel peptides and method for altering the activity of allosteric proteins |
| 08/05/1993 | WO1993014779A1 Trypsin inhibitors |
| 08/05/1993 | WO1993014778A1 Ex vivo gene transfer |
| 08/05/1993 | WO1993014776A1 Icam-related protein |
| 08/05/1993 | WO1993014768A1 Methods and compositions for neutralizing intracellular nucleic acid-binding protein biological activity in a cell, including methods and compositions useful to regulate gene function |
| 08/05/1993 | WO1993014641A1 Novel bacillus thuringiensis isolates active against phthiraptera pests |
| 08/05/1993 | WO1993014640A1 Antibacterial agent and treatment of article therewith |
| 08/05/1993 | WO1993014634A1 Protective effects of mutated superantigens |
| 08/05/1993 | WO1993013204A3 Agent for stimulating animal cell division |
| 08/05/1993 | WO1993012781A3 Creatine analogs having antiviral activity |
| 08/05/1993 | WO1993009234A3 Suppressor and progenitor cells |
| 08/05/1993 | WO1993009233A3 Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states |
| 08/05/1993 | WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 08/05/1993 | DE4203040A1 Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel New parathyroid hormone fragment, containing their production and this drug |
| 08/05/1993 | CA2129350A1 Immunological analogs for captan |
| 08/05/1993 | CA2129115A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 08/05/1993 | CA2129107A1 Novel bacillus thuringiensis isolates active against phthiraptera pests |
| 08/05/1993 | CA2129106A1 Process for controlling scarab pests with bacillus thuringiensis isolates |
| 08/05/1993 | CA2129019A1 Growth factor compositions, preparation and use |
| 08/05/1993 | CA2128896A1 Hepatitis therapeutics |
| 08/05/1993 | CA2128879A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | CA2128877A1 Amino procollagen 1(1) peptides |
| 08/05/1993 | CA2128722A1 Novel protein tyrosine kinases |
| 08/05/1993 | CA2128700A1 Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor |
| 08/05/1993 | CA2128616A1 Ex vivo gene transfer |
| 08/05/1993 | CA2128415A1 Protective effects of mutated superantigens |
| 08/05/1993 | CA2128110A1 Dna encoding kappa-casein, process for obtaining the protein and use thereof |
| 08/05/1993 | CA2126974A1 New parathormone fragments, their preparation and medicaments containing these |
| 08/05/1993 | CA2126092A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium |
| 08/05/1993 | CA2125979A1 New polypeptides with a stimulating activity for granulocytes colonies; process for preparing the same and pharmaceutical compositions containing them |
| 08/05/1993 | CA2125877A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
| 08/05/1993 | CA2117428A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 08/05/1993 | CA2107363A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 08/05/1993 | CA2106382A1 Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof |
| 08/04/1993 | EP0554064A1 Vaccine against schistosomiasis |
| 08/04/1993 | EP0553667A1 Soluble LDL receptor, its production and use |
| 08/04/1993 | EP0553494A1 Recombinant gene coding for human alpha interferon and expression vector thereof, ETC. |
| 08/04/1993 | EP0553428A2 DNA 5' to an untranslated region upstream of a gene encoding a growth hormone receptor. Use as a sex promoter |
| 08/04/1993 | EP0553312A1 Synthetic calcitonin peptides |
| 08/04/1993 | EP0553287A1 Cytokine-induced marker for inflammatory response |
| 08/04/1993 | EP0553281A1 Preparation and characterization of liposomal formulations of tumor necrosis factor. |
| 08/04/1993 | EP0553260A1 Substantially pure interleukin-9 receptor and uses thereof |
| 08/04/1993 | EP0553244A1 Targeted immunostimulation with bispecific reagents |
| 08/04/1993 | EP0553198A1 Regulation of immunoglobulin production by interleukin-9 |
| 08/04/1993 | EP0553186A1 Method for producing t h?-independent cytotoxic t lymphocytes |
| 08/04/1993 | EP0553117A1 Genetically engineered coccidiosis vaccine |
| 08/04/1993 | EP0553113A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 08/04/1993 | EP0553088A1 Promotion of maturation of hematopoietic progenitor cells |
| 08/04/1993 | EP0359789B1 Amplification and detection of nucleic acid sequences |
| 08/04/1993 | EP0218652B1 A dna sequence |
| 08/04/1993 | EP0203093B1 Monoclonal antibodies against alveolar surfactant protein |
| 08/04/1993 | EP0201511B1 Alpha-amidation enzyme |
| 08/04/1993 | EP0198026B1 Monoclonal antibodies to cyclosporings |